These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33970290)

  • 1. The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study.
    Lago TR; Brownstein MJ; Page E; Beydler E; Manbeck A; Beale A; Roberts C; Balderston N; Damiano E; Pineles SL; Simon N; Ernst M; Grillon C
    Psychopharmacology (Berl); 2021 Sep; 238(9):2393-2403. PubMed ID: 33970290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.
    Grillon C; Chavis C; Covington MF; Pine DS
    Neuropsychopharmacology; 2009 Mar; 34(4):964-71. PubMed ID: 18800069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
    Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.
    Grillon C; Heller R; Hirschhorn E; Kling MA; Pine DS; Schulkin J; Vythilingam M
    Biol Psychiatry; 2011 Mar; 69(6):549-55. PubMed ID: 21277566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of Anxiety-Potentiated Startle After Treatment With Escitalopram or Mindfulness Meditation in Anxiety Disorders.
    Hoge EA; Armstrong CH; Mete M; Oliva I; Lazar SW; Lago TR; Grillon C
    Biol Psychiatry; 2024 Jan; 95(1):85-92. PubMed ID: 37331547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
    Grillon C; Hale E; Lieberman L; Davis A; Pine DS; Ernst M
    Neuropsychopharmacology; 2015 Mar; 40(5):1064-71. PubMed ID: 25430779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.
    Baas JM; Mol N; Kenemans JL; Prinssen EP; Niklson I; Xia-Chen C; Broeyer F; van Gerven J
    Psychopharmacology (Berl); 2009 Jul; 205(1):73-84. PubMed ID: 19415242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained threat and phasic fear in the laboratory and cognitive-emotional processes of anxiety in everyday life - An ambulatory assessment study.
    Zänkert S; Lindl A; Schmitz A; Kudielka BM; Mühlberger A; Wüst S
    Int J Psychophysiol; 2022 May; 175():8-17. PubMed ID: 35217111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in hormonal modulation of anxiety measured with light-enhanced startle: possible role for arginine vasopressin in the male.
    Toufexis D; Davis C; Hammond A; Davis M
    J Neurosci; 2005 Sep; 25(39):9010-6. PubMed ID: 16192392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defensive activation to (un)predictable interoceptive threat: The NPU respiratory threat test (NPUr).
    Schroijen M; Fantoni S; Rivera C; Vervliet B; Schruers K; van den Bergh O; van Diest I
    Psychophysiology; 2016 Jun; 53(6):905-13. PubMed ID: 26879710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging.
    Fabio K; Guillon C; Lacey CJ; Lu SF; Heindel ND; Ferris CF; Placzek M; Jones G; Brownstein MJ; Simon NG
    Bioorg Med Chem; 2012 Feb; 20(3):1337-45. PubMed ID: 22249122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis?
    Robinson OJ; Overstreet C; Allen PS; Pine DS; Grillon C
    Neuropsychopharmacology; 2012 Jul; 37(8):1963-71. PubMed ID: 22491355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction.
    Hogle JM; Kaye JT; Curtin JJ
    Biol Psychiatry; 2010 Oct; 68(8):719-25. PubMed ID: 20673878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare scare: The role of intolerance of uncertainty in startle responses and event-related potentials in anticipation of unpredictable threat.
    Carsten HP; Härpfer K; Riesel A
    Int J Psychophysiol; 2022 Sep; 179():56-66. PubMed ID: 35787439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the time course of anticipatory anxiety using the fear-potentiated startle reflex.
    Grillon C; Ameli R; Merikangas K; Woods SW; Davis M
    Psychophysiology; 1993 Jul; 30(4):340-6. PubMed ID: 8327619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
    Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
    Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
    Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
    Neuropsychopharmacology; 2009 May; 34(6):1533-42. PubMed ID: 19078950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of threat of electric shock and diazepam on the N1/P2 auditory-evoked potential elicited by low-intensity auditory stimuli.
    Al-Abduljawad KA; Baqui F; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2008 Nov; 22(8):828-35. PubMed ID: 18208937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline and fear-potentiated startle in panic disorder patients.
    Grillon C; Ameli R; Goddard A; Woods SW; Davis M
    Biol Psychiatry; 1994 Apr; 35(7):431-9. PubMed ID: 8018793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.